Nada K. Sedky

531 citations
29 papers · 409 indexed · h-index 12
Topics
Nanoparticle-Based Drug Delivery (5 papers)Bioactive Compounds and Antitumor Agents (4 papers)RNA Interference and Gene Delivery (4 papers)

In The Last Decade

Nada K. Sedky

29 papers receiving 405 citations

Peers

Nada K. Sedky
Comparison fields: 5 of 76
  • Molecular Biology 154
  • Organic Chemistry 94
  • Biomaterials 62
  • Materials Chemistry 54
  • Plant Science 48
Replace Zahra Saffari with:
Zahra Saffari Iran
Mohammed Bhia Iran
Afaf Aldahish Saudi Arabia
Su Ji Kim South Korea
Iten M. Fawzy Egypt
Ömer Erdoğan Türkiye
Mayilaadumveettil Nishana India
Hossein Sadeghpour Iran
Ferah Cömert Önder Türkiye
Rohit Dutt India
Nada K. Sedky relative to Zahra Saffari Iran Zahra Saffari's profile →
Citations per field
00.5×3.8×
Zahra Saffari · 1×
Citations per year

Countries citing papers authored by Nada K. Sedky

Since Specialization
Citations

This map shows the geographic impact of Nada K. Sedky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada K. Sedky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada K. Sedky more than expected).

Fields of papers citing papers by Nada K. Sedky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada K. Sedky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada K. Sedky. The network helps show where Nada K. Sedky may publish in the future.

Co-authorship network of co-authors of Nada K. Sedky

This figure shows the co-authorship network connecting the top 25 collaborators of Nada K. Sedky. A scholar is included among the top collaborators of Nada K. Sedky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada K. Sedky. Nada K. Sedky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 4
3 6
4 3
5 10
6 1
7 10
8 7
9 4
10 29
11 14
12 8
13 27
14 9
15 13
16 28
17 18
18 85
19 22
20 10

About Nada K. Sedky

Nada K. Sedky is a scholar working on Toxicology, Biochemistry and Biomaterials, having authored 29 papers that have together received 409 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Toxicology (18 citations), Biomaterials (62 citations) and Pharmaceutical Science (27 citations). Nada K. Sedky has collaborated with scholars based in Egypt, Germany and United Kingdom. Frequent co-authors include Reem K. Arafa, Sherif Ashraf Fahmy, Mohamed S. Nafie, R.A. Youness, Iten M. Fawzy, Hassan Mohamed El-Said Azzazy, Fatma Alzahraa Mokhtar, Udo Bakowsky, Marwa Y. Issa and Hatem A. F. M. Hassan. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026